Image

Investigating the Impact of GLP-1 RA Therapy on Osteosarcopenia in Older Female Adults With Diabetes

Studying diabetes medication effects on bone and muscle health in older women.

Recruiting
65 years and older
Female
Phase 3
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study is for older women over 65 with type 2 diabetes. The main goal is to see if a medication called **GLP-1 RA** (Glucagon-like peptide-1 receptor agonist) affects muscle and bone health. **Osteosarcopenia** is when muscles and bones get weaker, which can lead to falls and fractures. This is a big concern for older women with diabetes.

Participants will be on GLP-1 RA therapy, which is already part of their regular care. During the study, they will have tests to check muscle strength, like a hand grip test, and bone health through blood tests and bone density scans. The study lasts 6 months, and participants won't have to change their usual treatment plans.

The study will help understand if GLP-1 RA therapy affects muscle strength and bone health in these women. This knowledge will help doctors support women with diabetes better in the future.

  • Study lasts 6 months with routine and special tests.
  • Participants receive GLP-1 RA therapy as usual care.
  • No alteration in their current treatment; focus is on observation.
Print
Study details
    Diabetes Mellitus
    Type 2

NCT07428746

Emory University

17 October 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Race*
Are you a healthy volunteer
Ethnicity*
Are you a healthy volunteer
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.